Clinical Trials on Embolic Stroke of Undetermined Source in Chile

Total 11 results

Population Health Research Institute

Completed

Young ESUS Patient Registry (Y-ESUS)

Embolic Stroke of Undetermined Source

Australia, United Kingdom, Canada, France, United States, Germany, Spain, Argentina, Chile, Mexico, Poland, South Africa, Switzerland
Universidad del Desarrollo
Pontificia Universidad Catolica de Chile

Completed

Performance Evaluation of Four Pharmacokinetic-Pharmacodynamic(PKPD) Models of Propofol in Elderly Patients (TCIGeriatric)

Propofol Overdose of Undetermined Intent

Chile
Pontificia Universidad Catolica de Chile

Completed

Influence of Aging on Perioperative Methadone Dosing

Pain, Postoperative | Opioid Use | Methadone Overdose of Undetermined Intent

Chile
Bayer
Janssen Research & Development, LLC; Population Health Research Institute

Terminated

Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS) (NAVIGATE ESUS)

Stroke

Denmark, France, Spain, China, United States, Switzerland, Germany, Greece, Korea, Republic of, Portugal, Japan, Israel, Canada, Australia, Turkey, Russian Federation, Sweden, Austria, Czechia, Poland, United Kingdom, Belgium, Brazil, Hungar... and more
Universidad de La Frontera

Completed

Predictors Factors and Time of Onset of Spasticity and Their Relationship With the Functionality and Quality of Life.

Post Stroke Spasticity

Chile
Universidad de La Frontera

Completed

Prevalence of Postural Patterns of Upper Extremity. (Patterns)

Stroke | Upper Extremity Paresis | Spasticity as Sequela of Stroke

Chile
Boehringer Ingelheim

Completed

Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)

Stroke | Secondary Prevention

Korea, Republic of, United States, Spain, Canada, Germany, Taiwan, Belgium, Australia, Hong Kong, India, Singapore, Thailand, Greece, Italy, Japan, China, Turkey, Russian Federation, Serbia, Switzerland, Israel, South Africa, Malaysia, Fran... and more
Abbott Medical Devices

Completed

AMPLATZER™ LAA Occluder Post Approval Study (PAS)

Stroke | Atrial Fibrillation | Thromboembolism

Canada, Italy, Spain, Argentina, Belgium, Chile, Germany
Daiichi Sankyo, Inc.
The TIMI Study Group

Completed

Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation (EngageAFTIMI48)

Stroke | Embolism | Atrial Fibrillation

United States, Australia, France, Italy, Poland, Taiwan, Ukraine, United Kingdom, China, Belgium, Germany, Spain, Argentina, Colombia, Israel, Mexico, Portugal, Bulgaria, India, Romania, Russian Federation, Serbia, South Africa, Turkey, Korea, Republic of and more
Abbott Medical Devices

Completed

Amplatzer™Amulet™ Post-Market Study (Amulet™PMS) (Amulet™PMS)

Stroke | Atrial Fibrillation | Thromboembolism

Denmark, Finland, Poland, Italy, Spain, United Kingdom, Germany, Israel, Ireland, Norway, Australia, Belgium, Chile, France, Netherlands, Sweden
Johnson & Johnson Pharmaceutical Research & Development...
Bayer

Completed

An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation

Stroke | Embolism | Atrial Fibrillation

United States, Australia, France, Poland, Ukraine, United Kingdom, China, Belgium, Germany, Taiwan, Spain, Argentina, Colombia, Israel, Mexico, Bulgaria, India, Malaysia, Romania, Russian Federation, South Africa, Turkey, Korea, Republic... and more

Clinical Trials on Embolic Stroke of Undetermined Source in Chile

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations